Resembling the work using anti-HMGB1 antibodies, animal studies revealed that HMGB1 Box A treatment prevented the proinflammatory cytokine effects of HMGB1 and improved both infectious and non-infectious diseases [67]. Here, HMGB1 is linked to infectious disease.